NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 241 filers reported holding NOVOCURE LTD in Q3 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,931,645 | +1045.2% | 48,747 | +4120.5% | 0.01% | +1300.0% |
| Q2 2021 | $256,000 | -97.9% | 1,155 | -98.8% | 0.00% | -96.7% |
| Q1 2021 | $12,275,000 | -67.2% | 92,866 | -57.1% | 0.03% | -61.0% |
| Q4 2020 | $37,446,000 | -28.9% | 216,400 | -54.3% | 0.08% | -40.8% |
| Q3 2020 | $52,694,000 | +514.5% | 473,400 | +227.4% | 0.13% | +333.3% |
| Q2 2020 | $8,575,000 | +65.4% | 144,602 | +87.9% | 0.03% | -3.2% |
| Q1 2020 | $5,184,000 | -40.7% | 76,970 | -25.8% | 0.03% | -31.1% |
| Q4 2019 | $8,747,000 | +1883.4% | 103,799 | +1659.3% | 0.04% | +1400.0% |
| Q3 2019 | $441,000 | -62.1% | 5,900 | -73.4% | 0.00% | -40.0% |
| Q3 2018 | $1,163,000 | – | 22,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |